Featured Firms
Presented by BigVoodoo
An investment group that signed an agreement capping the amount of shares it was allowed to trade in a biotechnology company cannot be sued for disgorgement of short-swing profits, the 2nd U.S. Circuit Court of Appeals ruled Thursday. Upholding the dismissal of a shareholder derivative suit, the court said the stockholder was shielded from short-swing liability because it wasn't a "beneficial owner" of ImmunoGen Inc.
August 23, 2001 at 12:00 AM
1 minute read
The original version of this story was published on Law.Com
Presented by BigVoodoo
Law firms & in-house legal departments with a presence in the middle east celebrate outstanding achievement within the profession.
The premier educational and networking event for employee benefits brokers and agents.
The Legal Intelligencer honors lawyers leaving a mark on the legal community in Pennsylvania and Delaware.
A large and well-established Tampa company is seeking a contracts administrator to support the company's in-house attorney and manage a wide...
We are seeking an attorney to join our commercial finance practice in either our Stamford, Hartford or New Haven offices. Candidates should ...
We are seeking an attorney to join our corporate and transactional practice. Candidates should have a minimum of 8 years of general corporat...
MELICK & PORTER, LLP PROMOTES CONNECTICUT PARTNERS HOLLY ROGERS, STEVEN BANKS, and ALEXANDER AHRENS